Blue Owl Capital (NYSE: OWL)’s arm that invests in other alternative asset managers is nearing a deal to acquire a minority stake in healthcare-focused private equity firm Linden Capital Partners, according to people with knowledge of the matter.
To read the entire story, you must be logged in.
Please log in now or register with us.
